V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 280006442 | 280003950 | 1.61 | 125 | Palliative (P) | 2016-07-11 | 2016-07-14 | Dacarbazine | N | N | 280018081 | IVA |
| 280006443 | 280008148 | null | null | Palliative (P) | null | 2014-08-27 | CARBOPLATIN + PACLITAXEL + RT | Y | null | 280018104 | DOCETAXEL + GEMCITABINE |
| 280006444 | 280003951 | null | null | Curative (C) | 2016-10-23 | 2016-11-11 | Cisplatin + Etoposide (3 day) | N | N | 280018117 | CISPLATIN + FLUOROURACIL + RT |
| 280006445 | 280003951 | null | null | Palliative (P) | null | 2016-10-25 | FLUOROURACIL + MITOMYCIN + RT | null | null | 280018117 | PACLITAXEL |
| 280006446 | 280003952 | null | 50.05 | null | 2016-11-16 | 2016-11-16 | ECX | 02 | N | 280018345 | CISPLATIN + ETOPOSIDE |
| 280006447 | 280008150 | 1.56 | 57.7 | Neo-adjuvant (N) | null | 2016-08-14 | CARBOPLATIN + PACLITAXEL + RT | null | null | 280018416 | PACLITAXEL |
| 280006448 | 280003953 | null | null | Palliative (P) | 2015-03-15 | 2015-04-06 | Gemcitabine weekly | N | null | 280018423 | DOXORUBICIN + OLARATUMAB |
| 280006449 | 280003953 | 1.76 | 65.6 | Adjuvant (A) | 2015-06-27 | 2015-07-01 | ECX | 02 | N | 280018423 | CISPLATIN + DOXORUBICIN |
| 280006450 | 280003954 | 1.84 | 92.7 | Palliative (P) | 2014-07-30 | 2014-07-30 | Cetuximab +Cisplatin + FU (Cycle 1) | Y | N | 280018485 | TRABECTEDIN |
| 280006451 | 280008152 | 1.77 | 81.3 | Palliative (P) | 2014-08-04 | 2014-08-25 | CAPECITABINE + TEMOZOLOMIDE | N | N | 280018500 | EPIRUBICIN |
| 280006452 | 280003955 | 1.97 | 92 | Neo-adjuvant (N) | 2015-08-18 | 2015-09-15 | FCiSt | 01 | Y | 280018515 | MAP |
| 280006453 | 280003955 | 1.68 | 100.6 | Palliative (P) | 2014-12-23 | 2015-01-03 | Erlotinib | 2 | N | 280018515 | LIPOSOMAL DOXORUBICIN |
| 280006454 | 280003956 | null | 76.6 | Palliative (P) | 2017-07-23 | 2017-07-23 | Oxaliplatin + Modified de Gramont | 02 | N | 280018569 | DOXORUBICIN + OLARATUMAB |
| 280006455 | 280003956 | 1.6 | 66.1 | Palliative (P) | 2017-02-24 | 2017-03-15 | Carboplatin + Pemetrexed | null | null | 280018569 | TRABECTEDIN |
| 280006456 | 280003956 | null | 76.7 | Neo-adjuvant (N) | 2017-11-21 | 2017-12-13 | Topotecan (intravenous) | N | N | 280018569 | CARBO + FLUOROURACIL |
| 280006457 | 280003956 | 1.67 | null | null | 2015-12-11 | 2015-12-24 | LANREOTIDE | Y | null | 280018569 | CARBO + FLUOROURACIL |
| 280006458 | 280003957 | 1.64 | 52.2 | Curative (C) | 2015-11-05 | 2015-11-05 | Cetuximab +Cisplatin + FU (Cycle 1) | N | N | 280018765 | BEAM |
| 280006459 | 280003958 | null | null | Curative (C) | null | 2013-12-05 | Carboplatin + Pemetrexed | null | null | 280018806 | CARBO + FLUOROURACIL |
| 280006460 | 280003958 | 1.59 | 62.3 | Palliative (P) | 2018-10-29 | 2018-10-29 | EURO-EWING | 02 | N | 280018806 | TRABECTEDIN |
| 280006461 | 280003959 | 1.81 | null | Palliative (P) | null | 2016-02-23 | STS Rhabdo RMS 2005 Vin Cyclo | null | null | 280018870 | CARBO + FLUOROURACIL |
| 280006462 | 280003959 | 1.55 | 53 | Disease modification (D) | 2017-12-16 | 2017-12-17 | Capecitabine + Oxaliplatin 21day | 02 | N | 280018870 | CAPECITABINE + CARBOPLATIN |
| 280006463 | 280003959 | 1.88 | 65.6 | Palliative (P) | 2015-03-11 | 2015-03-12 | EVEROLIMUS | N | N | 280018870 | CARBOPLATIN + CETUXIMAB + FU |
| 280006464 | 280003959 | 1.8 | null | Curative (C) | 2015-10-21 | 2015-10-22 | Liposomal Doxorubicin 50mg/m2 | N | null | 280018870 | IVA |
| 280006465 | 280003960 | 1.61 | null | Palliative (P) | 2011-04-06 | 2014-10-04 | Oxaliplatin + Modified de Gramont | 02 | Y | 280018942 | PACLITAXEL |
| 280006466 | 280003961 | 1.7 | 81.3 | Palliative (P) | 2016-08-19 | 2016-08-20 | DE-ESCALATE TRIAL | 2 | N | 280019073 | GEMCARBO |
| 280006467 | 280008157 | null | 59 | Adjuvant (A) | 2017-05-10 | 2017-05-10 | Cisplatin + Etoposide (3 day) | Y | N | 280019074 | ECX |
| 280006468 | 280003962 | 1.67 | 85.4 | Curative (C) | 2018-01-16 | 2018-01-19 | Capecitabine + Oxaliplatin 21day | N | N | 280019082 | RMS 2005 TRIAL |
| 280006469 | 280003963 | 1.71 | 58.6 | Not known (9) | 2013-04-18 | 2013-04-22 | CAPECITABINE + OXALIPLATIN | N | N | 280019086 | TCF |
| 280006470 | 280003964 | null | 70 | Palliative (P) | 2017-08-10 | 2017-08-10 | VAC | N | N | 280019109 | GEMCARBO |
| 280006471 | 280003965 | null | 64.2 | Palliative (P) | 2014-03-24 | 2014-04-07 | EW EuroEwing 99 : VIDE | N | N | 280019115 | DACARBAZINE + GEMCITABINE |
| 280006472 | 280003966 | 1.73 | 90.4 | Curative (C) | 2013-12-26 | 2013-12-26 | Cetuximab + CISPLATIN | N | N | 280019137 | VIDE |
| 280006473 | 280003967 | 0 | 72.15 | Palliative (P) | 2015-01-19 | 2015-02-08 | Docetaxel+Gemcitabine (no prior RT) | Y | N | 280019158 | TRABECTEDIN |
| 280006474 | 280003967 | 1.69 | 65.8 | Curative (C) | 2013-06-23 | 2013-06-23 | Imatinib 400mg | Y | N | 280019158 | RMS 2005 TRIAL |
| 280006475 | 280003968 | 1.58 | null | Curative (C) | 2016-09-05 | 2016-09-22 | Carboplatin + Pemetrexed | N | null | 280019180 | VIDE |
| 280006476 | 280003969 | 1.71 | 92.5 | Palliative (P) | 2016-12-20 | 2016-12-20 | Docetaxel+Gemcitabine (no prior RT) | 02 | N | 280019202 | CAPE + CARBOPLATIN + CETUXIMAB |
| 280006477 | 280003969 | 1.73 | 81.25 | null | null | 2015-05-20 | ECX | N | null | 280019202 | CARBO + FLUOROURACIL |
| 280006478 | 280003970 | 1.63 | 61.9 | Palliative (P) | 2018-09-11 | 2018-09-12 | STS Rhabdo RMS 2005 Vin Cyclo | 2 | N | 280019218 | CARBOPLATIN + VINORELBINE |
| 280006479 | 280003970 | 1.67 | 110 | Neo-adjuvant (N) | null | 2013-04-27 | IBRUTINIB | N | N | 280019218 | EURO-EWING |
| 280006480 | 280003971 | 1.65 | 67.1 | Curative (C) | 2016-11-10 | 2016-11-28 | DARS Trial | Y | N | 280019278 | DOXORUBICIN + HD MTX |
| 280006481 | 280003972 | 1.7 | 59.2 | Adjuvant (A) | 2013-06-15 | 2013-06-15 | Irinotecan + Modified De Gramont | 02 | N | 280019281 | GEMCARBO |
| 280006482 | 280003972 | null | null | null | 2015-06-26 | 2015-06-26 | Capecitabine (21days) + Carboplatin | null | null | 280019281 | PACLITAXEL |
| 280006483 | 280010137 | 1.76 | 100 | Neo-adjuvant (N) | 2014-09-02 | 2014-09-13 | VIDE | 01 | Y | 280019328 | ECX |
| 280006484 | 280003973 | null | 62.6 | Curative (C) | null | 2013-12-14 | MELPHALAN | null | null | 280019385 | BEAM |
| 280006485 | 280003974 | null | null | Curative (C) | null | 2013-12-05 | Carbo F | null | null | 280019395 | CISPLATIN + FLUOROURACIL + RT |
| 280006486 | 280003975 | 1.6 | 6.2 | Curative (C) | 2016-10-21 | 2016-10-30 | EW EuroEwing 99 : VIDE | 01 | N | 280019397 | VIDE |
| 280006487 | 280003976 | 1.84 | 0 | Palliative (P) | 2016-09-01 | 2016-09-04 | Doxorubicin + Olaratumab | N | N | 280019450 | DOXORUBICIN + OLARATUMAB |
| 280006488 | 280003976 | 1.49 | 66.4 | null | 2015-11-11 | 2015-12-07 | BCG Intravesical | N | N | 280019450 | CISPLATIN + DOXORUBICIN |
| 280006489 | 280003976 | 1.58 | 72.5 | Curative (C) | 2013-10-18 | 2013-11-07 | CAV | N | N | 280019450 | CISPLATIN + FLUOROURACIL + RT |
| 280006490 | 280003976 | 1.6 | 62.4 | Palliative (P) | 2017-09-15 | 2017-09-18 | IPILIMUMAB + NIVOLUMAB | Y | Y | 280019450 | DOXORUBICIN + OLARATUMAB |
| 280006491 | 280003977 | 0 | 66.2 | Palliative (P) | 2016-03-03 | 2016-03-24 | Cisplatin + Etoposide (3 day) | N | N | 280019574 | TRABECTEDIN |